Transcript Training
IMPLEMENTATION
José A. Bengoechea
Kick-off meeting Palma Mallorca
January 24th 2013
INBIONET TIMELINE
Submission………………11/01/2012 [15:14:49]
Invitation to negotiation……7/05/2012
21/05/2012 (first draft Annex I)
Annex I accepted by REA………18/7/2012
GA signature by REA…......11/09/2012
Project officer Mattia Zilli
1st of January 2013
Research
Training
INBIONET partners will combine their
experience and expertise to deliver a
state-of-the-art Research Programme in
the competitive field of “microbial antiimmunology” with the goal of identifying
novel therapies based on modulating the
host-pathogen interaction.
On the whole, it is expected that this training
programme will provide the recruited
scientists
with
the
scientific
and
complementary skills they will need for a
successful career in the field of
“microbial anti-immunology” either in academia
or industry.
WP1
Innate responses
WP5
Management
WP2
Pathogen replication
WP3 Training
TU1: Immune signaling
TU2: Animal models
TU3: Mucosal immunology
TU4: Entrepreneurship
TU5: Complementary skills
Academia
Industry
WP4
Science and
society
WP1 INNATE RESPONSES
Lead: TCD
Tasks are projects ESR1-ESR7; ER1-ER2
Annual report submitted to Supervisory Board
Milestones
M1: Implementation of cellular models to analyze the activation of PRRs
M2: Implementation cellular models to analyze the activation of IFN
Deliverables
D1: Identification PRRs and PAMPs responsible for defense responses;
D2: Viral and bacterial means to subvert type I IFN production,
D3: Identification pathways suitable for immunomodulation
WP2 PATHOGEN REPLICATION
Lead: MFPL
Tasks are projects ESR8-ESR11; ER3-ER4
Annual report submitted to Supervisory Board
Milestones
M1: Implementation in vivo models to measure mucosal immunity
M2: Implementation in vivo models to manipulate mucosal immunity
Deliverables
D1: Bacterial intracellular survival strategies;
D2: IFN control ofviruses and bacteria replication,
D3: In vivo strategies for immunomodulation
WP3 TRAINING
Lead: EPFL
Training Committee
Tasks
Embedding an ESR/ER into a research group.
Preparation of Personal Development Plan.
Establishment of INBIONET ESR/ER committees.
Monitoring and reviewing of the work plan and timelines (12 months).
Organization of TUs, including network workshops.
Organization of rotations between laboratories.
Organization of training sections of the network meetings.
Annual report submitted to Supervisory Board
WP3 TRAINING
Lead: EPFL
Milestones
M1: Affiliation Graduate Schools
M2: Personal Development Plan
M3: INBIONET ESR/ER committees
M4: Training units and network workshops*
M5: Rotations*
Deliverables
D1: ESR/ER personal career plans*;
D2: Research fellows progress reports*,
D3: Training units and network workshops*
WP3 TRAINING
Lead: EPFL
Local level
Graduate Schools
Local courses/seminars
Language courses
Network level
INBIONET web page
International meetings
Training units (TUs)
Network workshops (NWs)
Network meetings (NMs)
Secondments
Final INBIONET conference
WP3 TRAINING
Lead: EPFL
TU1 Experimental techniques of manipulation of
innate immune signaling by pathogens at the
cellular level.
TCD
M7
Dublin
TU2 Animal models in inflammation, animal
care and animal imaging.
MPFL
M9
Vienna
TU3
Identification
and
functional
characterization of innate immune cells in
mucosal tissues.
EPFL
M18
Lausanne
TU4 Know-how transfer and entrepreneurship.
ParcBit
M27
Palma
Mallorca
TU5 Complementary skills
ParcBit
*
*
WP3 TRAINING
Lead: EPFL
TU1 Experimental techniques of manipulation of
innate immune signaling by pathogens at the cellular level.
TCD, collaboration FISIB
Dublin (M7)
On-hands course on pathogen manipulation of innate immune signaling
cascades at the cellular levels
Offered ONLY to INBIONET fellows plus partners´ fellows (places available)
WP3 TRAINING
Lead: EPFL
NW 1 Advanced
topics in innate immune signaling
TCD, collaboration FISIB
Dublin (M7)
2 days lectures (keynote speakers), posters and oral presentations
Offered to INBIONET fellows plus institutions´ fellows (places available)
Gender issues: female speakers (magical figure of 40%)
Outreach sesion: “The host-pathogen arms race: stories from the front line”
WP3 TRAINING
Lead: EPFL
TU2 Animal models in inflammation, animal care and
animal imaging.
MPFL,
Vienna (M9)
Competence on animal techniques and experimental models useful for
inflammatory and infectious diseases (including ethical issues).
Offered ONLY to INBIONET fellows plus partners´ fellows (places available)
WP3 TRAINING
Lead: EPFL
NW 2 Animal
models in inflammation and infection
MPFL
Vienna (M9)
2 days lectures (keynote speakers), posters and oral presentations
Offered to INBIONET fellows plus institutions´ fellows (places available)
Gender issues: female speakers (magical figure of 40%)
Outreach sesion: ‘How infectious diseases change human life’.
WP3 TRAINING
Lead: EPFL
TU3 Identification and functional characterization of
innate immune cells in mucosal tissues.
EPFL, collaboration Preclin
Lausanne (M18)
On-hands course on analysis of mucosal innate immune responses.
Offered ONLY to INBIONET fellows plus partners´ fellows (places available)
WP3 TRAINING
Lead: EPFL
NW 3 Mucosal immunology
EPFL, collaboration Preclin
Lausanne (M7)
2 days lectures (keynote speakers), posters and oral presentations
Offered to INBIONET fellows plus institutions´ fellows (places available)
Gender aspects: female speakers (magical figure of 40%)
Outreach sesion: Mice, amoebas, flies and worms helping research’.
WP3 TRAINING
Lead: EPFL
TU4-NW4Know-how transfer and entrepreneurship.
ParcBit, collaboration FISIB
Palma Mallorca (M27)
Process of company creation in the European biotechnology sector.
Offered ONLY to INBIONET fellows plus partners´ fellows (places available)
Gender aspects: female speakers (magical figure of 40%)
Outreach sesion: “Translational medicine: from the lab to the company
to the bed”.
WP3 TRAINING
Lead: EPFL
TU5 Complementary skills
ParcBit, collaboration FISIB
Linked to the Network meetings
Offered ONLY to INBIONET fellows plus partners´ fellows (places available)
scientific communication skills; NM1-3
how to write scientific applications; NM3
career planning and job hunting; NM2-3
laboratory/group management. NM3
Keynote speaker ???
WP3 TRAINING
Lead: EPFL
Secondments
At least 2 per fellow
Academia and industry and vicerversa
At least 2 months, “fixed period”
1. IP (2 months, within M18-M24) to assess the modulation of ubiquitination by
Klebsiella spp.
2. Sanofi (4 months, within M26-M36) In vivo pneumonia model tagging bacteria
and host molecules.
WP4 SCIENCE and SOCIETY
Lead: USTAN
Tasks:
Advertising of INBIONET activities
Preparation and dissemination of INBIONET E-Newsletter.
INBIONET video clips.
Maintenance of INBIONET web page as open access
resource of data.
Dissemination via social media (Twitter and Blog).
Establishment and maintenance of links with national
Microbiology/Immunology Societies and local Graduate
schools.
Establishment and maintenance of contacts with European
research initiatives. (INFECT-ERA)
Outreach activities.
Development of an agenda for long lasting collaborations
between academic research groups and industry.
WP4 SCIENCE and SOCIETY
Lead: USTAN
Deliverables
D1: Social media accounts (Twitter, Blog)*;
D2: E-Newsletter *,
D3: INBIONET Video-clips *
WP4 SCIENCE and SOCIETY
Lead: USTAN
Outreach activities:
Twitter (@INBIONET)
INBIONET Blog (each fellow 2 post per yr)
Outreach reports (each fellow 2 per yr)
E-Newsletter (every 6 months)
INBIONET clips (each fellow 2)
Outreach sessions workshops
WP5 MANAGEMENT
Lead: FISIB
Tasks:
Organization of the kick-off meeting
Development of the INBIONET web site
Recruitment
Organization of the Network meetings (agenda, speakers,…)
Monitoring and evaluation of the WPs´ progress reports.
Organization of the mandatory Mid-term review.
WP5 MANAGEMENT
Lead: FISIB
Supervisory Board
Training Committee Recruitment Committee Patenting Committee Network Management
Supervisory Board
S trategic decision-making body
Formed by all partners and chaired by coordinator
Meeting once per yr during Network meetings
Consensus-voting rules (2/3 quorum; simple majority)
WP5 MANAGEMENT
Lead: FISIB
Supervisory Board
Training Committee Recruitment Committee Patenting Committee Network Management
Training committee
Responsible training programme, gender issues
TCD, MPFL, EPFL, ParcBit, FISIB, Preclin, Sanofi, one ESR (female)
Meeting once per yr during Network meetings
Consensus-voting rules (2/3 quorum; simple majority)
WP5 MANAGEMENT
Lead: FISIB
Supervisory Board
Training Committee Recruitment Committee Patenting Committee Network Management
Recruitment committee
Responsible recruitment, employment, gender issues
TCD, FISIB, EPFL, IP, Preclin
Meeting once per yr during Network meetings
Consensus-voting rules (2/3 quorum; simple majority)
WP5 MANAGEMENT
Lead: FISIB
Supervisory Board
Training Committee Recruitment Committee Patenting Committee Network Management
Patenting committee
Responsible exploitation issues, protection of intellectual property
FISIB, Preclin, Sanofi, ParcBit, IP
According to Consortium Agreement
Meeting once per yr during Network meetings
Consensus-voting rules (2/3 quorum; simple majority)
WP5 MANAGEMENT
Lead: FISIB
Coordinator
Project manager
Partners
Fellows
Work package leaders
Committee chairs
Supervisory Board
Work package leaders submit annual progress report
WP5 MANAGEMENT
Lead: FISIB
Management meetings
Kick-off meeting: Palma de Mallorca, hosted by FISIB (M1)
1st Network meeting: Vienna (Austria), hosted by MFPL (M12)
2nd Network meeting: Paris, hosted by IP (M21; mid-term review)
3rd Network meeting: Berlin, hosted by MPIIB (M30)
4th Final conference: Palma de Mallorca, hosted by FISIB and ParcBit (M41)
RECRUITMENT
Early Stage Researchers (ESR)
No PhD
Research experience ≤ 4* years
36 months
Experienced Researchers (ER) still in their early career
PhD or Research experience ≥ 4* years AND
Research experience ≤ 5* years
24 months
* counted from the diploma that gives the rights to embark in a doctoral degree
RECRUITMENT
RECRUITMENT
40% female researchers
RECRUITMENT
RECRUITMENT
RECRUITMENT
RECRUITMENT
….Teleconference coordinator…
Personal career development plan
Declaration of conformity
INBIONET ESR committee
Supervisor+colaborator+other ESR selected (non collaborator)
INBIONET ER committee
Supervisor+other ER selected
…Reports for Commission…
…Reports for INBIONET…
Annual progress report evaluated by INBIONET ESR/ER committee
Oral presentation evaluated by INBIONET ESR/ER committee
GENDER ASPECTS
40% of fellows
Keynote speakers (aiming 40%)
ESR appoint to Training committee will be female
Monitoring actions
Recruitment committee for working related
Training committee for training related
Training
Fellows' Recruitment
month
s
1
ESR1
ESR2
ESR3
ESR4
ESR5
ESR6
ESR7
ER1
ER2
ESR8
ESR9
ESR10
ESR11
ER3
ER4
TUs
Worksh
op
second
ments
On line
support
6
1
2
1
2
1
2
1
8
5
3
2
4
5
3
3
0
4
3
6
4
2
5
5
B
P
M
4
8
4
Management
Dissemin
Outreach
Meetin
gs
Social
media
Newslet
er
Clips
Blog
posts
Session
Reports
K
V
P
E
PROJECT MONITORING
Periodic and final reports are contractual deliverables
Research activities
Training activites
Management activities
Dissemination activities
IMMEDIATE ACTIONS
Committees
Recruitment call
Consortium Agreement
Animal permissions
Budget transfer
…going for dinner…